Case Report: Application of ex-vivo drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma
Diffuse midline glioma (DMG) is a pediatric brain cancer that has a dismal prognosis with limited treatment options. We present the treatment course and outcome of an adolescent male diagnosed with a thalamic DMG carrying a histone H3.3 K27M (H3K27M) alteration. Tumor biopsies were taken at diagnosi...
Saved in:
| Main Authors: | Philip K. Tan, Timothy J. Martins, Pamela S. Becker, Robert J. Wechsler-Reya, John Ross Crawford |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1606575/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma
by: Lei Cheng, et al.
Published: (2025-08-01) -
Diffuse midline glioma of the brainstem: genetic features, complications and treatment prospects
by: A. M. Kryanev, et al.
Published: (2024-06-01) -
H3 K27M-Altered Diffuse Midline Gliomas: A Review
by: Karol Wiśniewski, et al.
Published: (2023-08-01) -
Correlation between Head Midline Shift CT-Scan with Glasgow Coma Scale in Head Injury Patient at Waled General Hospital, Cirebon, Indonesia
by: Aditia Permana, et al.
Published: (2025-08-01) -
PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME
by: A. F. Valiakhmetova, et al.
Published: (2021-03-01)